Scientists at Ghent University have created a mouse model that incorporates human versions of the receptors that recognize the fragment crystallizable (Fc) region of immunoglobulin G (IgG), one of the ...

GV Safety Assessment Platform (GVSAP), an integrated preclinical R&D enabler within the GVRP portfolio, today announced an expansion of its strategic collaboration with Biocytogen (SSE: 688796; HKEX: ...

A new study from Karolinska Institutet shows that damage to small blood vessels in the hereditary disease CADASIL may disrupt ...

Human fetal tissue research has helped in the development of some vaccines.

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will summarize the bulls’ thesis on TWST. Twist Bioscience Corporation’s share was ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

Zuckerberg and Chan’s philanthropy is restructuring to prioritize A.I.-powered biomedical research over social programs.

Dr. Maarten Dewilde, an associate professor at KU Leuven, sat down with Technology Networks to discuss molecular engineering ...